Meghan Fitzgerald
CIK 1349297 · EVP, Strategy & Health Policy · last filed 2026-09-18
Meghan Fitzgerald is an EVP, Strategy & Health Policy who has filed 42 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ROIV, was dated Sep 18, 2026. Across all open-market trades the lifetime net is −$7.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.8M across reported positions. 14 SEC filings were submitted jointly with Roivant Sciences Ltd.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
Filer Profile
NAPLES, FL 34105
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | Director | 41,162 | $35.95 | $1.48M | -$3.27M | 13 | 2026-09-18 |
| THC | Director | 17,087 | $259.77 | $4.44M | -$3.68M | 15 | 2026-05-28 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Director | 1,152 | $2.75 | $3.2K | $0 | 2 | 2023-07-06 |
| CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Director | — | $8.37 | — | $0 | 3 | 2018-06-18 |
| CAH | EVP, Strategy & Health Policy | 16,760 | $229.85 | $3.85M | $0 | 3 | 2015-11-17 |
| VION PHARMACEUTICALS INC (VION) Delisted | VP and Chief Business Officer | 55,500 | — | — | $0 | 1 | 2007-03-14 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-18 | ROIV | Grant (A) | +5,054 | $0 | EDGAR |
| 2026-09-17 | ROIV | Sell (S) | −5,112 | -$203.2K | EDGAR |
| 2026-09-15 | ROIV | Notice (144) | −5,112 | -$209.7K | EDGAR |
| 2026-09-14 | ROIV | Tax (F) | −1,743 | -$71.4K | EDGAR |
| 2026-09-10 | ROIV | Mixed | — | -$622.0K | EDGAR |
| 2026-09-08 | ROIV | Notice (144) | −20,000 | -$698.6K | EDGAR |
| 2026-07-02 | ROIV | Mixed | — | -$261.0K | EDGAR |
| 2026-06-30 | ROIV | Notice (144) | −10,000 | -$347.3K | EDGAR |
| 2026-05-28 | THC | Grant (A) | — | $0 | EDGAR |
| 2026-05-26 | THC | Mixed | +840 | -$85.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.